India Glycols Share PriceIndia Glycols

₹702.85
11.85 (1.71%)
As on 25 September, 2023 | 21:09 BSE: 500201 NSE: INDIAGLYCOISIN: INE560A01015

India Glycols Performance

Day Range

  • Low 691.3
  • High 714.95
702.85

52 Week Range

  • Low 512.35
  • High 907.3
702.85
  • Open Price694
  • Previous Close691
  • Volume98655

Start SIP in India Glycols

Start SIP

India Glycols Share Price

  • Over 1 Month -7.44%
  • Over 3 Month 16.11%
  • Over 6 Month 17.52%
  • Over 1 Year -18.23%

India Glycols Key Statistics

P/E Ratio 14.8
PEG Ratio -2.3
Market Cap Cr 2,176
Price to Book Ratio 1.1
EPS 36.1
Dividend 1.1
Relative Strength Index 45.24
Money Flow Index 52.6
MACD Signal 6.36
Average True Range 24.42

India Glycols Investment Rating

  • Master Rating:
  • India Glycols (Nse) has an operating revenue of Rs. 2,531.81 Cr. on a trailing 12-month basis. An annual revenue de-growth of -7% needs improvement, Pre-tax margin of 6% is okay, ROE of 6% is fair but needs improvement. The company has a reasonable debt to equity of 29%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 5% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 72 which is a FAIR score but needs to improve its earnings, a RS Rating of 30 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 151 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

India Glycols Financials
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 688619553670808638
Operating Expenses Qtr Cr 592523481604745561
Operating Profit Qtr Cr 959772666377
Depreciation Qtr Cr 212920202019
Interest Qtr Cr 282626232017
Tax Qtr Cr 136387-8
Net Profit Qtr Cr 414013222319
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 2,6782,890
Operating Expenses Annual Cr 2,3532,611
Operating Profit Annual in Cr 298252
Depreciation Cr 9076
Interest Annual Cr 9562
Tax Annual Cr 2466
Net Profit Annual Cr 99285
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 90
Cash from Investing Activity Annual Cr 93
Cash from Financing Annual Activity Cr -180
Net Cash Flow Annual Cr 4
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 1,5881,512
Fixed Assets Annual Cr 2,8422,469
Total Non Current Assets Annual Cr 2,8952,623
Total Current Assets Annual Cr 1,6481,644
Total Assets Annual Cr 4,5434,267
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 513488
ROE Annual % 619
ROCE Annual % 98
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1210
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 689619554670808642
Operating Expenses Qtr Cr 589523485602746563
Operating Profit Qtr Cr 1009669686380
Depreciation Qtr Cr 213021212121
Interest Qtr Cr 282627242218
Tax Qtr Cr 136387-35
Net Profit Qtr Cr 514031252967
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 2,6752,890
Operating Expenses Annual Cr 2,3552,613
Operating Profit Annual in Cr 296255
Depreciation Cr 9480
Interest Annual Cr 10070
Tax Annual Cr 2439
Net Profit Annual Cr 125340
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 91
Cash from Investing Activity Annual Cr 93
Cash from Financing Annual Activity Cr -181
Net Cash Flow Annual Cr 4
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 1,9011,792
Fixed Assets Annual Cr 2,8422,561
Total Non Current Assets Annual Cr 3,2123,023
Total Current Assets Annual Cr 1,6461,607
Total Assets Annual Cr 4,8584,631
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 614572
ROE Annual % 719
ROCE Annual % 87
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1210

India Glycols Technicals

EMA & SMA

Current Price
₹702.85
11.85 (1.71%)
  • Bullish Moving Average
  • ___
  • 9
  • Bearish Moving Average
  • ___
  • 7
  • 20 Day
  • ₹717.52
  • 50 Day
  • ₹697.42
  • 100 Day
  • ₹673.9
  • 200 Day
  • ₹679.88
  • 20 Day
  • ₹734.08
  • 50 Day
  • ₹690.07
  • 100 Day
  • ₹652.01
  • 200 Day
  • ₹652.88

India Glycols Resistance and Support

PIVOT
₹703.04
Resistance
First Resistance ₹714.77
Second Resistance ₹726.69
Third Resistance ₹738.42
RSI 45.24
MFI 52.6
MACD Single Line 6.36
MACD -2.12
Support
First Resistance ₹691.12
Second Resistance ₹679.39
Third Resistance ₹667.47

India Glycols Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 106,246 4,221,154 39.73
Week 97,295 4,367,550 44.89
1 Month 198,335 9,422,896 47.51
6 Month 172,846 7,584,464 43.88

India Glycols Result Highlights

India Glycols Synopsis

NSE-Chemicals-Specialty

India Glycols is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 2650.08 Cr. and Equity Capital is Rs. 30.96 Cr. for the Year ended 31/03/2023. India Glycols Ltd. is a Public Limited Listed company incorporated on 19/11/1983 and has its registered office in the State of Uttarakhand/Uttaranchal, India. Company’s Corporate Identification Number(CIN) is L24111UR1983PLC009097 and registration number is 009097.
Market Cap 2,169
Sales 2,530
Shares in Float 1.21
No of funds 47
Yield 1.09
Book Value 1.37
U/D Vol ratio 2.4
LTDebt / Equity 35
Alpha -0.12
Beta 1.18

India Glycols

Owner NameJun-23Mar-23Dec-22Sep-22
Promoters 61.01%61.01%61.01%61.01%
Mutual Funds 0.15%2.41%2.41%2.64%
Insurance Companies 1.82%1.76%1.34%1.11%
Foreign Portfolio Investors 1.16%1.17%1.22%1.31%
Financial Institutions/ Banks 0.01%
Individual Investors 27.62%25.88%25.88%25.81%
Others 8.24%7.77%8.14%8.11%

India Glycols Management

Name Designation
Mr. U S Bhartia Chairman & Managing Director
Mr. Sudhir Agarwal Executive Director
Mr. Pragya Bhartia Barwale Executive Director
Mr. Pradip Kumar Khaitan Independent Director
Mr. Jitender Balakrishnan Independent Director
Mr. Ravi Jhunjhunwala Independent Director
Mr. Jagmohan N Kejriwal Independent Director
Mr. Sajeve Bhushan Deora Independent Director
Ms. Shukla Wasson Independent Director
Mrs. Jayshree Bhartia Director

India Glycols Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

India Glycols Corporate Action

Date Purpose Remarks
2023-08-07 Quarterly Results
2023-05-24 Audited Results & Final Dividend
2023-02-08 Quarterly Results
2022-11-10 Quarterly Results
2022-08-09 Quarterly Results

India Glycols MF Shareholding

Name Amount(cr)
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth 3174
Quant Value Fund Regular Growth 768
Motilal Oswal Nifty Microcap 250 Index Fund Regular Growth 324
  • Company Name
  • CMP
  • Chg(%)
  • Company Name
  • CMP
  • Chg(%)

India Glycols FAQs

What is Share Price of India Glycols ?

India Glycols share price is ₹702 As on 25 September, 2023 | 20:55

What is the Market Cap of India Glycols ?

The Market Cap of India Glycols is ₹2176.1 Cr As on 25 September, 2023 | 20:55

What is the P/E ratio of India Glycols ?

The P/E ratio of India Glycols is 14.8 As on 25 September, 2023 | 20:55

What is the PB ratio of India Glycols ?

The PB ratio of India Glycols is 1.1 As on 25 September, 2023 | 20:55

Q2FY23